Advanced therapy medicinal products: a comprehensive overview for pharmacy professionals An overview of the clinical, institutional, regulatory, safety and economic considerations of advanced therapy medicinal products.…
Understanding mRNA vaccine technologies An outline of how mRNA vaccines work and how pharmacists can educate and advise other healthcare professionals and patients on their background, clinical uses and safety.…
Formulation matters: safe oral hydrocortisone use in children The considerations for pharmacists when choosing a hydrocortisone formulation for children, and what advice and practical support should be offered.…
Appropriate prescribing practices and considerations: a hospital pharmacist’s perspective (audio) How pharmacists can implement age-appropriate prescribing and choose the right formulation in practice.…
We must learn the lessons from Priadel The discontinuation of Priadel shows we need a tougher regulatory environment to prevent firms making commercial decisions that put vulnerable patients at risk.…
UK could see ‘influx of counterfeit medicines’ without FMD after Brexit, warns RPS The UK could see “an influx of counterfeit medicines” after the Falsified Medicines Directive ceases to apply at the end of the Brexit transition period on 1 January 2021, the Royal Pharmaceutical Society has warned.…
Competition watchdog launches investigation into discontinuation of bipolar drug The Competition and Markets Authority has launched an investigation into Essential Pharma’s decision to discontinue the first-line treatment for bipolar disorder, Priadel.…
NHS England boss accuses Priadel manufacturer of using COVID-19 to ‘price-gouge’ British taxpayers The chief executive of NHS England has accused the manufacturer of a first-line medication for bipolar disorder of “trying to jack the prices of a long-standing medicine”.…
Warwick Smith: ‘The pandemic has removed factors that allowed us to be resilient for Brexit’ The director general of the British Generic Manufacturers Association speaks about how manufacturers are planning to juggle Brexit with COVID-19, and what the government can do to help.…
Health bodies make ‘urgent’ call to Matt Hancock to intervene in the proposed withdrawal of bipolar drug The health secretary, Matt Hancock, has been urged to “personally intervene” so that bipolar drug Priadel remains available in the UK with an appropriate pricing structure.…